Bulletin
Investor Alert

New York Markets Open in:

Context Therapeutics Inc.

NAS: CNTX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 23, 2022, 7:59 p.m.

/zigman2/quotes/228313454/composite

$

1.95

Change

+0.05 +2.63%

Volume

Volume 32,485

Quotes are delayed by 20 min

/zigman2/quotes/228313454/composite

Previous close

$ 1.77

$ 1.90

Change

+0.13 +7.34%

Day low

Day high

$1.69

$2.00

Open

52 week low

52 week high

$1.27

$10.87

Open

Insider Actions for Context Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
12/16/2021 Martin A. Lehr
Chief Executive Officer; Director
13,000   Acquisition at $3.22 per share. 41,860
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
10,000   Acquisition at $5 per share. 50,000
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
10,000   Acquisition at $5 per share. 50,000
10/22/2021 Alex Levit
Chief Legal Officer, Corp. Sec
3,000   Acquisition at $5 per share. 15,000
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
586,475   Derivative/Non-derivative trans. at $0 per share. 0
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
210,715   Derivative/Non-derivative trans. at $0 per share. 0
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
586,476   Derivative/Non-derivative trans. at $0 per share. 0
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
210,722   Derivative/Non-derivative trans. at $0 per share. 0
10/22/2021 Evan G. Dick
SVP of R&D
26,587   Derivative/Non-derivative trans. at $0 per share. 0
10/22/2021 Evan G. Dick
SVP of R&D
26,587   Derivative/Non-derivative trans. at $0 per share. 0
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
52,680   376,135
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
52,680   376,135

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
1 Purchases
0 Sales
13,000
0
Last 12 months
12 Purchases
0 Sales
1,788,922
0

Officers and Executives

Mr. Martin A. Lehr
President, Chief Executive Officer & Director
Ms. Jennifer Minai-Azary
Chief Financial Officer & Treasurer
Dr. Tarek Sahmoud
Chief Medical Officer
Dr. Evan G. Dick
Senior Vice President-Research & Development
Dr. Felix Kim
Advisor
Mr. Christopher Beck
Senior Vice President-Operations
Dr. Mark Fletcher
Vice President-Research & Development
Ms. Elizabeth Nemchik
Controller
Mr. Alex Levit
Secretary & Chief Legal Officer
Mr. Richard J. Berman
Chairman
Ms. Jennifer Evans Stacey
Independent Director
Dr. Philip Wayne Kantoff
Independent Director
Ms. Linda B. West
Independent Director
Link to MarketWatch's Slice.